Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001753926-25-000125·Chancellor Michael B
Schedule 13D ownership disclosure
LIPELLA PHARMACEUTICALS INC.
Common Stock, par value $0.0001 per share · CUSIP: 53630L209
Event date: 2025-01-21
- Filing-level shares
- 209,640.00
- Percent of class
- 11.5%
- Michael B. ChancellorReported CIK 0001959360
Shares: 209,640.00 · Class: 11.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-000125
- Form type
- SCHEDULE 13D/A
- Filer
- Chancellor Michael B
- CIK
- CIK 1959360
- Filed
- Jan 23, 2025
- Reporting period
- Jan 21, 2025
- Description
- Schedule 13D beneficial ownership